Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
07/2010
07/21/2010CN101780028A Compound gel composition using adapalene and diphenyl acid peroxide as major ingredients
07/21/2010CN101537012B Complex vitamin freeze-dried powder injection and preparation method thereof
07/21/2010CN101427988B Moisture paper tissue containing hamamelidaceae plant extract liposome
07/21/2010CN101380310B Composition of bFGF modified liposome and shRNA expression vector targeting human VEGF gene and preparation method thereof
07/21/2010CN101357956B Purification method of polyvinyl alcohol resin
07/21/2010CN101352426B Osmotic pump controlled release preparation composition and preparation thereof
07/21/2010CN101265312B Amphipathic three block copolymer and its preparation method and application
07/21/2010CN101249070B 2-methoxy estradiol vena nano emulsions
07/21/2010CN101229376B Medicine compounds containing isosorbide mononitrate for treating high blood pressure
07/21/2010CN101224187B Dual functional polymer nanometer glue bunch and preparing method and application in preparing medicine for treating second narrow blood vessel
07/21/2010CN101167717B Novel isosorbide mononitrate injection
07/21/2010CN101152167B Isoliquirtigenin pessary for treating chronic cervicitis and method of preparing the same
07/21/2010CN101138545B Clathrate compound containing ginsenoside Rg2 and method of preparing the same
07/21/2010CN101129385B Ophthalmic composition containing gatifloxacin and lotepredenol etabonate and method of preparing the same
07/21/2010CN101121004B Medicine composition containing insulin intensifier and miglitol
07/21/2010CN101077340B Penetration-promoting type catablasm matrix
07/21/2010CN101062028B Combination including taxanes, the preparing method and the use thereof
07/21/2010CN101007011B Ginsenoside Rh2 self-emulsifying composition and its preparation method
07/21/2010CN101002942B PEG type elaioplast nanometer particle
07/21/2010CA2690354A1 Compositions and methods to cross link polymer fibers
07/20/2010US7759526 Pharmaceutical compositions comprising cannabidiol derivatives
07/20/2010US7759386 Oral administering; drug with carrier and excipient
07/20/2010US7759368 Sustained release composition for oral administration of niacin
07/20/2010US7759334 Soluble forms of amoxicillin and treatment of animals
07/20/2010US7759328 Formeratol and budesonide for treatment of respiratory system disorders such as chronc obstructive pulmonary disease
07/20/2010US7759322 Method of treating dry eye disease with purinergic receptor agonists
07/20/2010US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor
07/20/2010US7759082 Electroprocessed fibrin-based matrices and tissues
07/20/2010US7759070 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
07/20/2010US7758893 Enteral compositions for the prevention and/or treatment of sepsis
07/20/2010US7758890 Treatment using dantrolene
07/20/2010US7758887 Warming and nonirritating lubricant compositions and method of comparing irritation
07/20/2010US7758877 Storage stable liquid suspension for oral administration comprising an antihistamine selected from loratadine, descarboethoxyloratadine, azatadine and/or salts; and surfactant; oxidation resistance; water, glycerin, sorbitol, propylene glycol, and thickener
07/20/2010US7758873 Polysaccharide containing botulinum toxin pharmaceutical compositions and uses thereof
07/20/2010US7758871 Relieving spastic muscle pain; ultrasonic frequency disruption of stratum corneum and applying patch containing neurotoxin
07/20/2010US7758869 Immunization of animal; mixture with solid phase lipid; oral administering
07/20/2010US7758861 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions
07/20/2010CA2455680C Ophthalmic depot formulations for periocular or subconjunctival administration
07/20/2010CA2446942C Use of il-18 inhibitors for the treatment or prevention of sepsis
07/20/2010CA2444533C Pharmaceutical vehicle
07/20/2010CA2442415C Medical aerosol formulations
07/20/2010CA2411831C Pharmaceutical compositions comprising cannabidiol derivatives
07/20/2010CA2329659C Perfluorinated esters of alkanoyl l-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds
07/20/2010CA2288983C Covalently linked n,o-carboxymethylchitosan and uses thereof
07/20/2010CA2282906C Stable complexes of poorly soluble compounds
07/20/2010CA2197563C Capsular polysaccharide immunomodulator
07/20/2010CA2197235C Adenovirus comprising a gene coding for glutathion peroxidase
07/15/2010WO2010081032A2 Steroidal compositions
07/15/2010WO2010080754A2 Nanoparticle pharmaceutical formulations
07/15/2010WO2010080720A2 Conjugates of a lysosomal enzyme moiety and a water soluble polymer
07/15/2010WO2010080622A1 Drug delivery devices for delivery of therapeutic agents
07/15/2010WO2010080618A2 Porous reactive frameworks
07/15/2010WO2010080580A2 Extended-release pharmaceutical formulations
07/15/2010WO2010080570A2 Tumor therapy with antitumor agents in combination with sindbis virus-based vectors
07/15/2010WO2010079310A1 Pharmaceutical composition containing malathion and a volatile cyclic silicone
07/15/2010WO2010079052A2 Nanoparticle compositions
07/15/2010WO2010079037A2 Aqueous dispersion comprising pesticide particles and an amphiphile
07/15/2010WO2010078950A2 Antigens associated with endometriosis, psoriatic arthritis and psoriasis
07/15/2010WO2010078945A2 Cancer treatment
07/15/2010WO2010078916A1 Immunocytokines for tumour therapy with chemotherapeutic agents
07/15/2010WO2010078675A1 The drug delivery vehicle using gold-magnetic composite particles coated by polysaccharides and its preparation
07/15/2010WO2010058902A3 Thermosensitive composition preventing tissue adhesion and preparation method thereof
07/15/2010WO2010048478A3 Tablets and discs with compartments with two or more drugs for release at certain intervals and with specific rates
07/15/2010WO2010039762A3 Pharmaceutical compositions comprising boronic acid compounds
07/15/2010WO2009158412A3 Sustained delivery of exenatide and other polypeptides
07/15/2010WO2009149058A8 Modified release niacin formulations
07/15/2010WO2009144577A3 Anionic polyamide functionalized by a tryptophan unit
07/15/2010WO2009105624A3 Simultaneous delivery of receptors and/or co-receptors for growth factor stability and activity
07/15/2010US20100179229 Method for modulating the taste of material compositions containing at least one high intensity sweetener (his)
07/15/2010US20100179212 Pharmaceutical composition which improves in vivo gene transfer
07/15/2010US20100179182 Pharmaceutical formulation
07/15/2010US20100179106 Mitochondrial compositions and uses thereof
07/15/2010US20100179103 Curcumin cyclodextrin combination for preventing or treating various diseases
07/15/2010US20100179095 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa
07/15/2010US20100178702 method for in vitro and/or ex vivo transferring molecule of interest to eukaryotic cell comprising step of:contacting eukaryotic cell with non-pathogenic amoeba Dictyostelium discoideum vesicle that contains a molecule of interest, under conditions sufficient to allow vesicle to fuse with eukaryotic cell
07/15/2010US20100178331 Preparation for transnasal application
07/15/2010US20100178318 Composite Structure Including A Low Vinyl Acetate Layer
07/15/2010US20100178315 Polymeric systems for controlled drug therapy
07/15/2010US20100178243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
07/15/2010DE102005058569B4 Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer Foam wafer with polyvinyl alcohol-polyethylene glycol graft
07/15/2010CA2782655A1 Nanoparticle pharmaceutical formulations
07/15/2010CA2748401A1 Antigens associated with endometriosis, psoriatic arthritis and psoriasis
07/15/2010CA2748291A1 Cancer treatment
07/15/2010CA2747505A1 Drug delivery devices for delivery of therapeutic agents
07/15/2010CA2747195A1 Dipeptide linked medicinal agents
07/15/2010CA2747154A1 Immunocytokines for tumour therapy with chemotherapeutic agents
07/15/2010CA2746968A1 Octreotide depot formulation with constantly high exposure levels
07/15/2010CA2746855A1 Extended-release pharmaceutical formulations
07/15/2010CA2746555A1 Nanoparticle compositions
07/15/2010CA2744266A1 Steroidal compositions
07/15/2010CA2649936A1 Honey product having a low water content
07/14/2010EP2206787A2 Peptide-enhanced transfections
07/14/2010EP2206773A1 Espansion of renewable stem cell populations
07/14/2010EP2206721A1 Neuromedin u derivative
07/14/2010EP2206720A1 Albumin fusion proteins
07/14/2010EP2206519A1 Medicinal preparation for oral administration
07/14/2010EP2206518A1 Pharmaceutical composition containing lipophilic il-2 production inhibitor
07/14/2010EP2206516A1 Stabilized liquid anti-RSV antibody formulations
07/14/2010EP2206504A1 Stable bicarbonate ion-containing drug solution
07/14/2010EP2206502A1 Polymer conjugate of steroid
1 ... 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 ... 1712